By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Addex Therapeutics (ADXN.SW)' Clinical Programs And Discovery Platform Highlighted In Review Of Allosteric Modulators For The Treatment Of Neurodegenerative Diseases 2/6/2017 8:42:58 AM
Addex Therapeutics (ADXN.SW) Awarded $835,000 Grant From The Michael J. Fox Foundation To Advance TrkB PAMs For The Treatment Of Parkinson's Disease 1/31/2017 10:17:14 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Statistically Significant Efficacy In A Highly Translational Preclinical Model Of Chronic Osteoarthritis Pain 1/9/2017 9:48:15 AM
Addex Therapeutics (ADXN.SW) ADX71441 Pharmacological Profile Published In Neuropharmacology 12/13/2016 8:36:27 AM
Addex Therapeutics (ADXN.SW) Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., As Chief Medical Officer 11/28/2016 7:30:48 AM
Addex Therapeutics (ADXN.SW) To Conduct Phase IIa Proof Of Concept Study Of Dipraglurant In Focal Cervical Dystonia 10/17/2016 10:28:39 AM
Addex Therapeutics (ADXN.SW) Initiates New Study In Collaboration With U.S. National Institute on Drug Abuse (NIDA) With ADX88178 In Non-Human Primate Model Of Cocaine Addiction 10/11/2016 10:23:25 AM
Addex Therapeutics (ADXN.SW) Reports First Half 2016 Operating Highlights And Financial Results 9/30/2016 8:42:20 AM
Addex Therapeutics (ADXN.SW) Collaborators Published New Data Supporting The Role Of Negative Allosteric Modulators Of Follicle Stimulating Hormone And Luteinizing Hormone Receptors In Reproductive Health 9/20/2016 9:14:43 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016 9:33:32 AM
12345678910...
//-->